Bridgeway Capital Management’s Nu Skin NUS Stock Holding History

Bridgeway Capital Management’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.67M	Sell	317,074 -142,858	-31%	-$913K	0.03%	616
2026 Q1	$3.35M	Sell	459,932 -9,881	-2%	-$89.5K	0.07%	356
2025 Q4	$4.52M	Buy	469,813 +73,088	+18%	+$756K	0.09%	276
2025 Q3	$4.84M	Buy	396,725 +181,601	+84%	+$1.91M	0.1%	262
2025 Q2	$1.72M	Buy	215,124 +165,124	+330%	+$1.16M	0.04%	556
2025 Q1	$363K	Sell	50,000 -153,000	-75%	-$1.11M	0.01%	803
2024 Q4	$1.4M	Hold	203,000	–	–	0.03%	596
2024 Q3	$1.5M	Buy	+203,000	New	+$1.9M	0.03%	586
2014 Q4	–	Sell	-24,500	Closed	-$1.1M	–	1491
2014 Q3	$1.1M	Hold	24,500	–	–	0.03%	717
2014 Q2	$1.81M	Hold	24,500	–	–	0.05%	544
2014 Q1	$2.03M	Hold	24,500	–	–	0.06%	485
2013 Q4	$3.39M	Buy	+24,500	New	+$2.88M	0.1%	242

Other funds holding NUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bridgeway Capital Management's NUS Position: Q2 2026 in Review

Bridgeway Capital Management reduced its Nu Skin (NUS) stake by 31% in Q2 2026, selling an estimated $913K and leaving 317,074 shares worth $1.67M. The position accounts for 0.03% of the portfolio, ranked #616.

Bridgeway Capital Management first reported a position in NUS in Q4 2013 and has held it in 12 quarters since. The position peaked at $4.84M in Q3 2025. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

Bridgeway Capital Management held 317,074 shares of Nu Skin worth $1.67M as of Q2 2026.
Bridgeway Capital Management sold 142,858 Nu Skin shares in Q2 2026, an estimated $913K.
Nu Skin made up 0.03% of Bridgeway Capital Management's portfolio in Q2 2026, its #616 holding.
Bridgeway Capital Management first reported a position in Nu Skin in Q4 2013 and has held it in 12 quarters since.
Bridgeway Capital Management's Nu Skin position peaked at $4.84M in Q3 2025.
162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.